Literature DB >> 20581470

Cross-linking of ΔF508-CFTR promotes its trafficking to the plasma membrane.

Karen Bernard1, Kevin L Kirk.   

Abstract

CFTR is a cAMP-activated chloride channel responsible for agonist stimulated chloride and fluid transport across epithelial surfaces.(1) Mutations in the CFTR gene lead to cystic fibrosis (CF) which affects the function of secretory organs like the intestine, the pancreas, the airways and the sweat glands. Most of the morbidity and mortality in CF has been linked to a decrease in airway function.(2) The ΔF508 mutation is the most common CF-related mutation in the Caucasian population and represents 90% of CF alleles. Homozygote carriers of this mutation present with a severe CF phenotype.(3) The ΔF508 mutation causes misfolding of the nascent CFTR polypeptide, which leads to inefficient export from the endoplasmic reticulum (ER) and rapid degradation by the proteasome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20581470      PMCID: PMC3230517          DOI: 10.4161/chan.4.4.12198

Source DB:  PubMed          Journal:  Channels (Austin)        ISSN: 1933-6950            Impact factor:   2.581


  13 in total

1.  Curcumin opens cystic fibrosis transmembrane conductance regulator channels by a novel mechanism that requires neither ATP binding nor dimerization of the nucleotide-binding domains.

Authors:  Wei Wang; Karen Bernard; Ge Li; Kevin L Kirk
Journal:  J Biol Chem       Date:  2006-12-18       Impact factor: 5.157

2.  Curcumin stimulates cystic fibrosis transmembrane conductance regulator Cl- channel activity.

Authors:  Allan L Berger; Christoph O Randak; Lynda S Ostedgaard; Philip H Karp; Daniel W Vermeer; Michael J Welsh
Journal:  J Biol Chem       Date:  2004-12-06       Impact factor: 5.157

3.  Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules.

Authors:  Fredrick Van Goor; Kimberly S Straley; Dong Cao; Jesús González; Sabine Hadida; Anna Hazlewood; John Joubran; Tom Knapp; Lewis R Makings; Mark Miller; Timothy Neuberger; Eric Olson; Victor Panchenko; James Rader; Ashvani Singh; Jeffrey H Stack; Roger Tung; Peter D J Grootenhuis; Paul Negulescu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-01-27       Impact factor: 5.464

4.  Design and synthesis of a hybrid potentiator-corrector agonist of the cystic fibrosis mutant protein DeltaF508-CFTR.

Authors:  Aaron D Mills; Choong Yoo; Jeffrey D Butler; Baoxue Yang; A S Verkman; Mark J Kurth
Journal:  Bioorg Med Chem Lett       Date:  2009-11-13       Impact factor: 2.823

5.  Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects.

Authors:  Marie E Egan; Marilyn Pearson; Scott A Weiner; Vanathy Rajendran; Daniel Rubin; Judith Glöckner-Pagel; Susan Canny; Kai Du; Gergely L Lukacs; Michael J Caplan
Journal:  Science       Date:  2004-04-23       Impact factor: 47.728

6.  Molecular assembly of cystic fibrosis transmembrane conductance regulator in plasma membrane.

Authors:  Chunying Li; Koushik Roy; Keanna Dandridge; Anjaparavanda P Naren
Journal:  J Biol Chem       Date:  2004-04-01       Impact factor: 5.157

7.  Degradation of CFTR by the ubiquitin-proteasome pathway.

Authors:  C L Ward; S Omura; R R Kopito
Journal:  Cell       Date:  1995-10-06       Impact factor: 41.582

8.  Rescuing cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by transcomplementation.

Authors:  Estelle Cormet-Boyaka; Michael Jablonsky; Anjaparavanda P Naren; Patricia L Jackson; Donald D Muccio; Kevin L Kirk
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-12       Impact factor: 11.205

Review 9.  Functions of the cystic fibrosis transmembrane conductance regulator protein.

Authors:  R A Frizzell
Journal:  Am J Respir Crit Care Med       Date:  1995-03       Impact factor: 21.405

Review 10.  Clinical implications of cystic fibrosis transmembrane conductance regulator mutations.

Authors:  J E Mickle; G R Cutting
Journal:  Clin Chest Med       Date:  1998-09       Impact factor: 2.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.